OBJECTIVE: The goal of the present study was to evaluate the effects of bilateral deep brain stimulation (DBS) of the subthalamic nucleus (STN) on olfaction in patients with Parkinson's disease (PD). METHODS: 15 patients suffering from sporadic PD-related dysosmia were implanted with bilateral electrodes aimed at the STN. One week before the surgery, odor detection threshold (DT) and identification threshold (IT) were evaluated in all patients using the 'five odor olfactory detection arrays' in both medication-off and medication-on conditions. 15 healthy age-matched controls also received the same olfactory evaluation. Patient evaluations were repeated at 6 and 12 months postoperatively in a medication-off/stimulator-on or medication-off/stimulator-off condition. Odor DT and IT scores were compared pre- and postoperatively, as well as between the medication-off/stimulator-on or -off conditions. RESULTS: The motor symptoms of all 15 PD patients, including rigidity, tremor, bradykinesia, postural instability, and gait were significantly improved after stimulator implantation. The UPDRS motor (UPDRS III) scores decreased significantly in the medication-off/stimulator-on condition (p < 0.01). The odor DT and IT scores of PD patients were higher than those of healthy controls (p < 0.01). In the medication-off/stimulator-off condition, there was no significant difference in the odor DT and IT scores in PD patients pre- vs. postoperatively (p > 0.05). Notably, there were no significant alterations to DT scores in the stimulator-on and -off conditions at the 6- and 12-month follow-up (p > 0.05), whereas IT scores were significantly improved in the stimulation-on relative to the stimulation-off condition at the 6- and 12-month follow-up. CONCLUSIONS: STN DBS can significantly improve olfactory cognitive function in PD patients. The possible mechanisms include an improvement in striatal metabolism and neuronal activity in the orbitofrontal cortex mediated by STN DBS, as well as increased glucose metabolism in the striatum, midbrain, cingulate gyrus, and motor and higher-order somatosensory association cortices. (c) 2008 S. Karger AG, Basel
OBJECTIVE: The goal of the present study was to evaluate the effects of bilateral deep brain stimulation (DBS) of the subthalamic nucleus (STN) on olfaction in patients with Parkinson's disease (PD). METHODS: 15 patients suffering from sporadic PD-related dysosmia were implanted with bilateral electrodes aimed at the STN. One week before the surgery, odor detection threshold (DT) and identification threshold (IT) were evaluated in all patients using the 'five odor olfactory detection arrays' in both medication-off and medication-on conditions. 15 healthy age-matched controls also received the same olfactory evaluation. Patient evaluations were repeated at 6 and 12 months postoperatively in a medication-off/stimulator-on or medication-off/stimulator-off condition. Odor DT and IT scores were compared pre- and postoperatively, as well as between the medication-off/stimulator-on or -off conditions. RESULTS: The motor symptoms of all 15 PDpatients, including rigidity, tremor, bradykinesia, postural instability, and gait were significantly improved after stimulator implantation. The UPDRS motor (UPDRS III) scores decreased significantly in the medication-off/stimulator-on condition (p < 0.01). The odor DT and IT scores of PDpatients were higher than those of healthy controls (p < 0.01). In the medication-off/stimulator-off condition, there was no significant difference in the odor DT and IT scores in PDpatients pre- vs. postoperatively (p > 0.05). Notably, there were no significant alterations to DT scores in the stimulator-on and -off conditions at the 6- and 12-month follow-up (p > 0.05), whereas IT scores were significantly improved in the stimulation-on relative to the stimulation-off condition at the 6- and 12-month follow-up. CONCLUSIONS:STN DBS can significantly improve olfactory cognitive function in PDpatients. The possible mechanisms include an improvement in striatal metabolism and neuronal activity in the orbitofrontal cortex mediated by STN DBS, as well as increased glucose metabolism in the striatum, midbrain, cingulate gyrus, and motor and higher-order somatosensory association cortices. (c) 2008 S. Karger AG, Basel
Authors: Takao Hashimoto; Christopher M Elder; Michael S Okun; Susan K Patrick; Jerrold L Vitek Journal: J Neurosci Date: 2003-03-01 Impact factor: 6.167
Authors: Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak Journal: Neurobiol Aging Date: 2003 Mar-Apr Impact factor: 4.673
Authors: P Perozzo; M Rizzone; B Bergamasco; L Castelli; M Lanotte; A Tavella; E Torre; L Lopiano Journal: J Neurol Sci Date: 2001-11-15 Impact factor: 3.181
Authors: Alberto J Espay; Joe P Giuffrida; Robert Chen; Megan Payne; Filomena Mazzella; Emily Dunn; Jennifer E Vaughan; Andrew P Duker; Alok Sahay; Sang Jin Kim; Fredy J Revilla; Dustin A Heldman Journal: Mov Disord Date: 2011-09-23 Impact factor: 10.338
Authors: Antje Haehner; Clara Tosch; Martin Wolz; Lisa Klingelhoefer; Mareike Fauser; Alexander Storch; Heinz Reichmann; Thomas Hummel Journal: PLoS One Date: 2013-04-17 Impact factor: 3.240
Authors: Jens Volkmann; Alberto Albanese; Angelo Antonini; K Ray Chaudhuri; Carl E Clarke; Rob M A de Bie; Günther Deuschl; Karla Eggert; Jean-Luc Houeto; Jaime Kulisevsky; Dag Nyholm; Per Odin; Karen Østergaard; Werner Poewe; Pierre Pollak; Jose Martin Rabey; Olivier Rascol; Evzen Ruzicka; Michael Samuel; Hans Speelman; Olof Sydow; Francesc Valldeoriola; Chris van der Linden; Wolfgang Oertel Journal: J Neurol Date: 2013-01-05 Impact factor: 4.849
Authors: Xiao-Hong Wang; Lin Zhang; Laura Sperry; John Olichney; Sarah Tomaszewski Farias; Kiarash Shahlaie; Norika Malhado Chang; Ying Liu; Su-Ping Wang; Cui Wang Journal: Chin Med J (Engl) Date: 2015-12-20 Impact factor: 2.628